Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life - A State-of-Art Review

Viviana Elian
ORCID logo ,
Violeta Popovici
* ,
Emma-Adriana Ozon
* ,
Adina Magdalena Musuc
ORCID logo ,
Ancuța Cătălina Fița
ORCID logo ,
Emilia Rusu
,
Gabriela Radulian
,
Dumitru Lupuliasa
Version 1 : Received: 31 May 2023 / Approved: 1 June 2023 / Online: 1 June 2023 (11:07:07 CEST)

A peer-reviewed article of this Preprint also exists.

Elian, V.; Popovici, V.; Ozon, E.-A.; Musuc, A.M.; Fița, A.C.; Rusu, E.; Radulian, G.; Lupuliasa, D. Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review. Life 2023, 13, 1663. Elian, V.; Popovici, V.; Ozon, E.-A.; Musuc, A.M.; Fița, A.C.; Rusu, E.; Radulian, G.; Lupuliasa, D. Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review. Life 2023, 13, 1663.

Abstract

Type 1 Diabetes mellitus (T1DM) occurs when insulin is not produced in the Pancreas due to the autoimmune destruction of the beta cells. The patients may be diagnosed after 80-90% of the beta cells are destroyed. Insulin remains the essential medicine in T1DM management, under continuous monitoring of glucose levels. T1DM management consists of a complex and precise set of self-care measures for the entire life; during this continuous process, the patients could become overwhelmed, angry, anxious, frustrated, and/or discouraged. Therefore, to be widely used and provide general benefits, new technologies for DM management must provide clinical advantages without compromising safety. The compliance of T1DM patients is also essential, thus improving their quality of life (QoL). Moreover, the accessibility of the new system for patients through healthcare coverage is critical; they must be able to buy the new devices and accessories and pay for their maintenance. In this context, our work aims to describe the most recent technologies regarding continuous glucose monitors (CGMs) and continuous subcutaneous insulin infusion (CSII) systems, correlated with psychosocial impact and capacity to improve T1DM patients' life quality.

Keywords

Type 1 Diabetes mellitus; Insulin; Diabetes management; Technology; Continuous glucose monitoring systems; Insulin pumps

Subject

Public Health and Healthcare, Primary Health Care

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF Download Supplementary

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Supplementary Files Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.